GMP Compliance for Production of CB.Hep-1 Monoclonal Antibody as a Biological Reagent - - BioPharm International

ADVERTISEMENT

GMP Compliance for Production of CB.Hep-1 Monoclonal Antibody as a Biological Reagent

16. Valdés R., García J., Reyes B., Muñoz L., Alvarez T., Padilla S., Abrahantes M.C., Zubiaurrez J., Agraz A., Marrero A., "A Very Sensitive Enzyme-linked Immunoabsorbent Assay to Staphylococcal Protein A in the Presence of Immunoglobulins," Biochemical and Biophysical Research Communications, Volume 303, Issue 3, 11 April 2003, Pages 863-867.

17. Hardy E., Martínez E., Diago D., Díaz R., González D., Herrera L., "Large-scale Production of Recombinant Hepatitis B Surface Antigen from Pichia Pastoris," Journal of Biotechnology, 77: 157–167, 2000.

18. Werz W., Hoffmann H., Haberer K., Walter J.K., "Strategies to Avoid Virus Transmissions by Biopharmaceutic Products," 1997.

19. Janet B., Elizabeth M., and Alexander F, "Viral Removal/Inactivation by Purification of Biopharmaceuticals," Biopharm 5, No. 9 (Nov-Dec, 1992): 22-30.


blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

PDA Announces Technical Report on Drug Shortages
September 9, 2014
European Commission Approves RoACTEMRA for Treatment of RA
September 9, 2014
DPT Laboratories Acquires Media Pharmaceuticals' Lakewood Facilities
September 5, 2014
Merck KGaA Breaks Ground on Facility in China
September 5, 2014
FDA Releases Guidance Electronic Submission of Lot Distribution Reports
September 5, 2014
Author Guidelines
Source: BioPharm International,
Click here